Pandemic Studios
Pandemic Studios was a video game developer that was started in 1998. It became owned by Electronic Arts from 2007 to 2009. It was an Australian and American company, with offices in Brisbane and Los Angeles.
| Subsidiary of Electronic Arts | |
| Industry | Interactive entertainment Computer and video games |
| Founded | Santa Monica, California, United States (1998) |
| Defunct | 2009 |
| Headquarters | Los Angeles, California, United States |
Key people | Andrew Goldman, CEO Josh Resnick, President |
| Website | http://www.pandemicstudios.com/ (archived version 2009) |
Pandemic Studios developed the first two main titles of the successful Star Wars: Battlefront series; those were Star Wars: Battlefront and Star Wars: Battlefront II. It also developed Full Spectrum Warrior, the Mercenaries series, and the last game in the Army Men series.
Their office in Brisbane was closed in February 2009.[1] In November 2009, Electronic Arts cut a total of 1,500 jobs, including at Pandemic. The company was officially closed on 17 November 2009. The rest of the staff were moved to EA Los Angeles to support Mercs Inc, a sequel to the Mercenaries series.[2][3]
Games developed (made)
- Battlezone II (1999)
- Dark Reign 2 (2000)
- Triple Play 2002 (2002)
- Army Men RTS (2002)
- Star Wars: The Clone Wars (2002)
- Full Spectrum Warrior (2004)
- Star Wars: Battlefront (2004)
- Star Wars: Battlefront II (2005)
- Mercenaries: Playground of Destruction (2005)
- Destroy All Humans! (2005)
- Destroy All Humans! 2 (2006)
- Mercenaries 2: World in Flames (2008)
- The Lord of the Rings: Conquest (2009)
- The Saboteur (2009)
References
- ↑ Pandemic Brisbane Shut Down. Ausgamers.com. February 11, 2009. http://www.ausgamers.com/news/read/2707354. Retrieved February 12, 2009.
- ↑ Stephen Totilo (November 24, 2009). "EA Makes Mercs Inc, A New "Pandemic" Game, Official [UPDATE]". Kotaku. Retrieved November 21, 2009.
- ↑ Brian Crecente (November 17, 2009). "Confirmed: EA Closes Pandemic Studios, Says Brand Will Live On". Kotaku. Retrieved November 17, 2009.